Zobrazeno 1 - 10
of 88
pro vyhledávání: '"V. A. Peterkova"'
Autor:
D. N. Laptev, I. A. Eremina, E. S. Shubina, T. E. Yankevich, E. A. Sechko, N. A. Goncharova, V. A. Peterkova
Publikováno v:
Сахарный диабет, Vol 27, Iss 4, Pp 313-320 (2024)
BACKGROUND: Type 1 diabetes mellitus (DM1) is a chronic autoimmune disease characterized by damage to insulin–producing cells of the pancreas, which eventually leads to the need for insulin replacement therapy. The clinical picture of DM1 is hetero
Externí odkaz:
https://doaj.org/article/bb712237c45849198c8aa7edb44db7ad
Autor:
D. N. Laptev, E. A. Sechko, E. M. Romanenkova, I. A. Eremina, O. B. Bezlepkina, V. A. Peterkova, N. G. Mokrysheva
Publikováno v:
Сахарный диабет, Vol 27, Iss 1, Pp 33-40 (2024)
BACKGROUND: MODY (maturity-onset diabetes of the young) is a rare monogenic form of diabetes mellitus, the gold standard of diagnosis is mutations detection in the genes responsible for the development of this form diabetes. Genetic test is expensive
Externí odkaz:
https://doaj.org/article/6688e80c546a4a2b829c97878dc31dc0
Autor:
E. M. Romanenkova, I. M. Zufarova, D. Y. Sorokin, I. A. Eremina, E. A. Sechko, L. V. Nikankina, V. A. Peterkova, O. B. Bezlepkina, D. N. Laptev
Publikováno v:
Сахарный диабет, Vol 26, Iss 3, Pp 204-212 (2023)
BACKGROUND: Type 1 diabetes mellitus (T1D) is an autoimmune disorder that leads to pancreatic β-cells destruction and progressive decrease of insulin secretion. Specific islet autoantibodies (AAbs) are the main diagnostic marker of T1D. Residual β-
Externí odkaz:
https://doaj.org/article/46ebafde09634348ba1e1b7a421f5ed1
Publikováno v:
Сахарный диабет, Vol 26, Iss 3, Pp 284-290 (2023)
Insulin resistance type A is a monogenic disorder with insulin action defect, observed in females with acanthosis nigricans (AN), hyperandrogenism, hyperinsulinemia, insulin resistance (IR) without obesity. We present a family case of diabetes mellit
Externí odkaz:
https://doaj.org/article/b3db784247d149b6a0a1e7aa85af569d
Autor:
E. A. Sechko, E. M. Romanenkova, I. A. Eremina, L. I. Zilberman, L. V. Nikankina, Z. T. Zuraeva, O. B. Bezlepkina, V. A. Peterkova, D. N. Laptev
Publikováno v:
Сахарный диабет, Vol 25, Iss 5, Pp 449-457 (2022)
BACKGROUND: T1D is characterized by autoimmune destruction of pancreatic β-cells, which develops due to genetic and environmental risk factors. Shortly after initiating the treatment with insulin, 80% of children with T1D may require smaller doses o
Externí odkaz:
https://doaj.org/article/2ccbc67cff294dadb606633ddbabed81
Autor:
T. V. Chubarov, V. A. Peterkova, G. A. Batischeva, O. A. Zhdanova, O. G. Sharshova, A. I. Artyushchenko, A. V. Bessonova
Publikováno v:
Ожирение и метаболизм, Vol 19, Iss 1, Pp 27-34 (2022)
BACKGROUND: Essential arterial hypertension (AH) develops more often in children with accompanying risk factors — obesity, overweight, positive heredity and genetic predisposition.AIM: Study of peculiarities of arterial hypertension clinical course
Externí odkaz:
https://doaj.org/article/c474dc0246bf42228c3d631de7e0ceba
Autor:
E. A. Sechko, T. L. Kuraeva, L. I. Zilberman, D. N. Laptev, O. B. Bezlepkina, V. A. Peterkova
Publikováno v:
Сахарный диабет, Vol 25, Iss 2, Pp 145-154 (2022)
BACKGROUND: Monogenic diabetes mellitus (MDM) is a rare form of diabetes mellitus (DM) which caused by one or more mutations in one of the genes that cause pancreatic β-cell dysfunction. Despite the sufficient knowledge of the most common subtypes o
Externí odkaz:
https://doaj.org/article/0a1ea31930b74524921be7eafbdbe310
Autor:
E. M. Romanenkova, I. A. Eremina, E. V. Titovich, E. A. Sechko, L. V. Nikankina, V. A. Peterkova, O. B. Bezlepkina, D. N. Laptev
Publikováno v:
Сахарный диабет, Vol 25, Iss 2, Pp 155-165 (2022)
BACKGROUND: Type 1 diabetes mellitus (T1DM) is characterized by the development of absolute insulin deficiency. In some patients residual insulin secretion may persist for a long time. C-peptide is a widely used to measure the pancreatic beta cells f
Externí odkaz:
https://doaj.org/article/8bac16334d734164ba83b7c610883fb8
Autor:
D. N. Laptev, A. O. Emelyanov, E. A. Andrianova, L. I. Zilberman, I. A. Eremina, G. N. Svetlova, E. V. Titovich, O. B. Bezlepkina, V. A. Peterkova
Publikováno v:
Сахарный диабет, Vol 24, Iss 6, Pp 504-510 (2022)
BACKGROUND: In 2018, a Frestyle Libre flash glucose monitoring system (FGM) appeared in Russia and became a potential alternative to the traditional CGM. Studies carried out to date have shown the advantages of FGM over SMBG, but only a few of them r
Externí odkaz:
https://doaj.org/article/11c965ef837642ccb517c1bf34e242ff
Autor:
D. N. Laptev, I. A. Eremina, A. V. Karpushkina, E. E. Petryaykina, O. B. Bezlepkina, V. A. Peterkova
Publikováno v:
Сахарный диабет, Vol 24, Iss 5, Pp 404-413 (2022)
Background: The prevalence of type 1 diabetes mellitus (T1DM) in childhood is increasing every year. Adolescence is the most challenging age for achieving optimal metabolic control of T1DM. Telemedicine has already been shown to be effective in chi
Externí odkaz:
https://doaj.org/article/39de400fb300484798bc0a7165fc0d02